Keyphrases
Bone Alkaline Phosphatase
100%
Skeletal Complications
100%
Hormone-sensitive Prostate Cancer
100%
Skeletal-related Events
80%
Alkaline Phosphatase Level
60%
Bone Metastasis
40%
Zoledronic Acid
40%
Multivariate Analysis
40%
Surgical Castration
40%
Relative Risk
20%
Disease Progression
20%
N-telopeptide
20%
Confidence Interval
20%
Placebo
20%
Radiotherapy
20%
Specific Marker
20%
Baseline Variables
20%
Acid Groups
20%
Lactate Dehydrogenase
20%
Hemoglobin
20%
Prostate-specific Antigen
20%
Most Common Form
20%
Eastern Cooperative Oncology Group Performance Status (ECOG PS)
20%
Bone Disease
20%
Randomized Placebo-controlled Trial
20%
Cox Proportional Hazard Analysis
20%
Osteoblastic Activity
20%
Pathologic Fracture
20%
Baseline Covariates
20%
Subset Analysis
20%
Prostate Cancer Metastasis
20%
Analgesic Use
20%
Osteoclastic Activity
20%
Medicine and Dentistry
Prostate Cancer
100%
Alkaline Phosphatase
100%
Population Research
40%
Zoledronic Acid
40%
Bone Metastasis
40%
Multivariate Analysis
40%
Placebo
40%
Malignant Neoplasm
20%
Metastatic Carcinoma
20%
Urinary System
20%
Proportional Hazards Model
20%
Telopeptide
20%
Disease Exacerbation
20%
Oncology
20%
Castration Resistant Prostate Cancer
20%
Prostate Specific Antigen
20%
Pathologic Fracture
20%
Lactate Dehydrogenase
20%
Radiation Therapy
20%
Pharmacology, Toxicology and Pharmaceutical Science
Alkaline Phosphatase
100%
Prostate Cancer
100%
Bone Metastasis
40%
Zoledronic Acid
40%
Placebo
40%
Population Study
40%
Malignant Neoplasm
20%
Metastasis
20%
Disease Exacerbation
20%
Telopeptide
20%
Lactate Dehydrogenase
20%
Prostate Specific Antigen
20%
Castration Resistant Prostate Cancer
20%
Analgesic Agent
20%
Pathologic Fracture
20%
Bone Disease
20%